Verseon (Verseon) EV-to-EBIT : -287.56 (As of Apr. 26, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Verseon EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Verseon's Enterprise Value is $6,711.05 Mil. Verseon's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was $-23.34 Mil. Therefore, Verseon's EV-to-EBIT for today is -287.56.

The historical rank and industry rank for Verseon's EV-to-EBIT or its related term are showing as below:

VERS' s EV-to-EBIT Range Over the Past 10 Years
Min: -287.56 Med: 0 Max: 0
Current: -287.56

VERS's EV-to-EBIT is not ranked
in the Biotechnology industry.
Industry Median: 8.41 vs VERS: -287.56

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Verseon's Enterprise Value for the quarter that ended in Jun. 2019 was $118.46 Mil. Verseon's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was $-23.34 Mil. Verseon's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2019 was -19.70%.

Verseon EV-to-EBIT Historical Data

The historical data trend for Verseon's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verseon EV-to-EBIT Chart

Verseon Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

EV-to-EBIT

Get a 7-Day Free Trial

-14.10

-11.78

-9.95

Verseon Semi-Annual Data
	Dec11	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19
EV-to-EBIT	Get a 7-Day Free Trial									-	-11.78	-	-9.95	-

Competitive Comparison of Verseon's EV-to-EBIT

For the Biotechnology subindustry, Verseon's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Verseon's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verseon's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Verseon's EV-to-EBIT falls into.

Verseon EV-to-EBIT Calculation

Verseon's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	6711.051	/	-23.338
	=	-287.56

Verseon's current Enterprise Value is $6,711.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Verseon's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was $-23.34 Mil.

Verseon (GREY:VERS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Verseon's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2019 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2019 )	=	EBIT	/	Enterprise Value (Q: Jun. 2019 )
	=	-23.338	/	118.45772
	=	-19.70 %

Verseon's Enterprise Value for the quarter that ended in Jun. 2019 was $118.46 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Verseon's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was $-23.34 Mil.

Verseon EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Verseon's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Verseon (Verseon) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (GREY:VERS) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

47071 Bayside Parkway, Fremont, CA, USA, 94538

Website

http://www.verseon.com

Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.